Respiratory Continuing Education
The burden of chronic obstructive pulmonary disease (COPD) has grown over the last several decades, particularly in specific populations such as women and individuals living in rural areas. COPD is not simply a “smoker’s cough” but an underdiagnosed, life-threatening lung disease. A multitude of factors must be considered when selecting the most appropriate inhaled medication for each patient with COPD. These factors include the patient’s ability to use the device properly, the need for multiple inhaled medications, convenience, patient preferences, clinical evidence, symptom burden, and exacerbation risk. In light of the numerous options available for maintenance therapy for patients with COPD, choosing the most appropriate treatment can be challenging. Moreover, the Global Initiative for Chronic Obstructive Lung Disease (GOLD) consistently updates management recommendations to reflect the latest advances and inform treatment selection. Despite these advances, the management of COPD remains inadequate. The Respiratory Education Hub has been developed to assist health care providers in the diagnosis and management of COPD with CME/CE certified activities from renowned experts in the field, animations that can be used as a teaching tool for team members and patients, and downloadable resources to use in practice.

Jump to:

 

Live & On-Demand Webcasts   CMEOCast Animations   Reading Room

The Role of Antibody Drug Conjugates in Advanced Non-Small Cell Lung Cancer: Guidance for Today and the Path Forward

 

Participate Now  

The discovery of molecular alterations that drive tumor initiation and progression has revolutionized the treatment strategy for non-small cell lung cancer (NSCLC) by matching targeted therapies to a specific mutation, leading to significantly improved therapeutic efficacy. However, despite the initial effectiveness of targeted therapy for NSCLC, most patients ultimately develop acquired resistance with subsequent disease progression, making it imperative for clinicians to receive up-to-date education on evaluating new therapeutic options to improve outcomes and better tailor treatment strategies.

In this CME Outfitters OnDemand, integrations of animated 3-D models will provide visual representation of the mechanisms and characteristics of antibody drug conjugates (ADCs) in NSCLC to complement expert faculty insights and evidence supporting testing strategies to identify predictive biomarkers, emerging treatment options for advanced or metastatic NSCLC, and best practices for managing patients with lung cancer in the face of COVID-19 and beyond.

The Pharmacist's Role in Improving Early Diagnosis for Patients with Chronic Cough

 

Participate Now  

This CME Outfitters podcast will present a patient case that shows how pharmacists can talk to patients presenting with cough, including recommending cough products, discussions about cough hypersensitivity syndrome, and facilitating patients who may have chronic cough to the next steps.

A Guide to New and Emerging Treatment Options for Chronic Cough

 

Participate Now  

In this CME Outfitters podcast, expert faculty will discuss new concepts related to our understanding of cough hypersensitivity and the data emerging from trials of new agents to build the foundation of these novel, targeted mechanisms, and the promise of these drug therapies to address unmet needs in chronic cough.

Top Takeaways from this Activity: SMART Goals

Animated Resources of the Lung and COPD

An Animated Look at COPD Treatments

Take a tour of the different treatments for COPD and their impact on alveoli and at the cellular level. Represented in the animations are short-acting bronchodilators, maintenance treatment with LAMA/LABA, LABA/ICS, LAMA/LABA/ICS.

 

 

An Animated Look at COPD

In this animation, you can take an animated tour of the lungs. Click on different parts of the anatomy to better understand the animation, click to zoom in, turn, or zoom out on the structure. In Chapter 1, we begin with healthy lung that you can move around to better understand. Chapter 2 illustrates COPD with hyperinflation. Moving to Chapter 3, we see healthy alveoli, before comparing alveoli in COPD with exacerbation in Chapter 4. Finally, in Chapter 5 you can see the increase in eosinophils.